(Q39572484)

13 September 2017

title

Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830090606

16 April 2022

Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A91516

16 April 2022

1 reference

https://api.crossref.org/works/10.1002/EJI.1830090606

16 April 2022

author name string

Fellous M

1

1 reference

13 September 2017

Kamoun M

2

1 reference

13 September 2017

Gresser I

3

1 reference

13 September 2017

Bono R

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 June 1979

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830090606

1 reference

https://api.crossref.org/works/10.1002/EJI.1830090606

https://onlinelibrary.wiley.com/doi/full/10.1002/eji.1830090606

16 April 2022

1 reference

https://api.crossref.org/works/10.1002/EJI.1830090606

European Journal of Immunology

16 April 2022

published in

1 reference

13 September 2017

volume

9

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

446-449

1 reference

Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L 1210 cells and their position in the cell cycle

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of ebv-negative lymphoma lines and theirin vitro EBV-converted sublines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

A method for the large scale production of potent interferon preparations.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

The study of human Aa-like specificities using antibody eluates from human lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Enhanced Expression of Histocompatibility Antigens on Interferon-Treated Mouse Embryonic Fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Serological identification of HL-A-linked human ‘Ia-type’ antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

HLA restriction of cell-mediated lysis of influenza virus-infected human cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830090606

7 January 2021

Identifiers

1 reference

13 September 2017

1 reference